Testmate Health, a Lausanne, Switzerland-based company which specialises in at-home testing solutions, raised $6M in Seed funding.
The round was led by RH Capital, with participation from The Helm, Zürcher Kantonal Bank, Amboy Street Ventures, Lichtsteiner Foundation, and Dartlabs.io.
The company intends to use the funds to develop an over-the-counter (OTC), self-test for sexually transmitted infections (STI), starting with chlamydia and gonorrhea.
Led by CEO Siew-Veena Sahi, Testmate Health is developing the first OTC self-test for common STIs. The urine test can be used anywhere at any time, providing accurate, lab-quality results in less than 30 minutes. The company was founded in 2021 and is comprised by a team of experts in sexual health and diagnostics.
FinSMEs
08/05/2024